Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.
Sri Lanka Clinical Trials Registry Committee, Wijerama Mawatha, Colombo, Sri Lanka.
J Evid Based Med. 2018 Feb;11(1):46-50. doi: 10.1111/jebm.12284. Epub 2018 Jan 11.
We describe our experience of the first 10 years at the Sri Lanka Clinical Trials Registry (SLCTR).
We analyzed all trial records of the SLCTR over the study period. We collected information regarding trial characteristics and completeness of data entry in the SLCTR data set.
During the study period, 210 trials (63% of all applications) were registered with the SLCTR. The number of registered trials showed an increasing trend over the years. All trial registrations had complete entries for all the data fields studied. Only 17.6% of the trials were registered retrospectively. All the registered trials were interventional studies, and the majority (87.6%) were randomized controlled trials. A significant proportion of trials (28.6%) were on noncommunicable diseases, and 12.4% were on pregnancy and its outcomes. Several trials (9.5%) were international collaborative studies. A majority of the Principal Investigators (70.9%) were affiliated to a university. Most of the studies (41.9%) were self-funded by the investigators. Details of ethics review committee approval were available for 96.7% of registered trials. Over a third of the registered trials (37.1%) had completed recruitment at the time of analysis. A majority of the trials (72.8%) had updated trial data since registration.
There is a steady increase in the number of trials registered at the SLCTR. Complete entries for all the data fields were seen in all trial registrations. The SLCTR has made a positive contribution to the emergence of a healthy clinical research environment in Sri Lanka.
我们描述斯里兰卡临床试验注册中心(SLCTR)成立头 10 年的经验。
我们分析了研究期间 SLCTR 的所有试验记录。我们收集了关于试验特征和 SLCTR 数据集数据录入完整性的信息。
在研究期间,有 210 项试验(占所有申请的 63%)在 SLCTR 注册。注册试验的数量呈逐年上升趋势。所有试验注册均对所有研究字段进行了完整录入。只有 17.6%的试验是回顾性注册。所有注册的试验均为干预性研究,其中大多数(87.6%)为随机对照试验。相当一部分试验(28.6%)为非传染性疾病,12.4%为妊娠及其结局。有几个试验(9.5%)为国际合作研究。大多数主要研究者(70.9%)隶属于大学。大多数研究(41.9%)由研究者自筹资金。已注册试验中有 96.7%提供了伦理审查委员会批准的详细信息。在分析时,已注册试验中有超过三分之一(37.1%)已完成招募。自注册以来,大多数试验(72.8%)已更新了试验数据。
在 SLCTR 注册的试验数量稳步增加。所有试验注册均完整录入了所有数据字段。SLCTR 为斯里兰卡出现健康的临床研究环境做出了积极贡献。